HK1032236A1 - New bicyclic amino-pyrazinone compounds, a processfor their preparation and pharmaceutical compositions containing them. - Google Patents

New bicyclic amino-pyrazinone compounds, a processfor their preparation and pharmaceutical compositions containing them.

Info

Publication number
HK1032236A1
HK1032236A1 HK01102868A HK01102868A HK1032236A1 HK 1032236 A1 HK1032236 A1 HK 1032236A1 HK 01102868 A HK01102868 A HK 01102868A HK 01102868 A HK01102868 A HK 01102868A HK 1032236 A1 HK1032236 A1 HK 1032236A1
Authority
HK
Hong Kong
Prior art keywords
processfor
preparation
pharmaceutical compositions
compositions containing
bicyclic amino
Prior art date
Application number
HK01102868A
Other languages
English (en)
Inventor
Guillaume De Nanteuil
Philippe Gloanec
Tony Verbeuren
Alain Rupin
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1032236A1 publication Critical patent/HK1032236A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01102868A 1999-06-15 2001-04-23 New bicyclic amino-pyrazinone compounds, a processfor their preparation and pharmaceutical compositions containing them. HK1032236A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907538A FR2795072B1 (fr) 1999-06-15 1999-06-15 Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1032236A1 true HK1032236A1 (en) 2001-07-13

Family

ID=9546789

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01102868A HK1032236A1 (en) 1999-06-15 2001-04-23 New bicyclic amino-pyrazinone compounds, a processfor their preparation and pharmaceutical compositions containing them.

Country Status (23)

Country Link
US (1) US6277851B1 (ja)
EP (1) EP1069132B1 (ja)
JP (1) JP3364472B2 (ja)
KR (1) KR100456796B1 (ja)
CN (1) CN1147489C (ja)
AT (1) ATE251177T1 (ja)
AU (1) AU766194B2 (ja)
BR (1) BR0002643A (ja)
CA (1) CA2312206C (ja)
DE (1) DE60005609T2 (ja)
DK (1) DK1069132T3 (ja)
EA (1) EA003209B1 (ja)
ES (1) ES2208239T3 (ja)
FR (1) FR2795072B1 (ja)
HK (1) HK1032236A1 (ja)
HU (1) HUP0002277A3 (ja)
NO (1) NO316650B1 (ja)
NZ (1) NZ505149A (ja)
PL (1) PL199522B1 (ja)
PT (1) PT1069132E (ja)
SE (1) SE1069132T5 (ja)
SI (1) SI1069132T1 (ja)
ZA (1) ZA200003034B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245356A1 (en) * 2000-02-29 2001-09-12 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003243657A1 (en) * 2002-06-26 2004-01-19 Bristol-Myers Squibb Company Amino-bicyclic pyrazinones and pyridinones
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20140350034A1 (en) * 2012-01-27 2014-11-27 Novartis Ag Aminopyridine derivatives as plasma kallikrein inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体
HUT77651A (hu) * 1994-12-22 1998-07-28 Biochem Pharma Inc. Oxazolo- és tiazolo[3,2-a]piridin-, pirrolo[1,2-a]pirazin- és pirido[2,1-c][1,4]tiazin-karboxamido-arginin-származékok, eljárás ezek előállítására és az ezeket tartalmazó gyógyszerkészítmények
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
EP0923372A4 (en) * 1996-02-22 2001-09-05 Merck & Co Inc PYRIDINONE THROMBINE INHIBITORS
AU3232597A (en) * 1996-06-18 1998-01-07 Warner-Lambert Company Pyrrolo{1,2-a}pyrazine-1,4-dione serine protease inhibitors
AU4172397A (en) * 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
DE69719775T2 (de) * 1996-10-24 2004-02-05 Merck & Co., Inc. Thrombin inhibitoren
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
EP1017383A4 (en) * 1997-09-23 2001-11-28 Merck & Co Inc THROMBIN INHIBITORS

Also Published As

Publication number Publication date
PL199522B1 (pl) 2008-09-30
EP1069132B1 (fr) 2003-10-01
DK1069132T3 (da) 2004-02-02
HU0002277D0 (en) 2000-08-28
ATE251177T1 (de) 2003-10-15
CA2312206A1 (fr) 2000-12-15
AU766194B2 (en) 2003-10-09
AU4086500A (en) 2000-12-21
FR2795072A1 (fr) 2000-12-22
SE1069132T5 (sv) 2004-01-07
DE60005609T2 (de) 2004-08-05
SE1069132T3 (sv) 2003-12-09
EA200000527A2 (ru) 2000-12-25
US6277851B1 (en) 2001-08-21
NO20002941D0 (no) 2000-06-08
ZA200003034B (en) 2001-01-11
HUP0002277A2 (hu) 2001-05-28
EA003209B1 (ru) 2003-02-27
HUP0002277A3 (en) 2002-12-28
CN1147489C (zh) 2004-04-28
EA200000527A3 (ru) 2001-04-23
ES2208239T3 (es) 2004-06-16
DE60005609D1 (de) 2003-11-06
KR20010066846A (ko) 2001-07-11
NO316650B1 (no) 2004-03-22
FR2795072B1 (fr) 2001-07-27
JP3364472B2 (ja) 2003-01-08
PL340784A1 (en) 2000-12-18
JP2001026592A (ja) 2001-01-30
CA2312206C (fr) 2004-07-06
CN1277198A (zh) 2000-12-20
SI1069132T1 (en) 2003-12-31
EP1069132A1 (fr) 2001-01-17
NZ505149A (en) 2001-01-26
BR0002643A (pt) 2001-01-02
KR100456796B1 (ko) 2004-11-10
PT1069132E (pt) 2004-02-27
NO20002941L (no) 2000-12-18

Similar Documents

Publication Publication Date Title
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
TW200612920A (en) Novel imidazolidine derivatives
NZ524475A (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU1463195A (en) Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors
NO950849D0 (no) Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter
MXPA05007496A (es) Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
EA200600487A1 (ru) Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции
IL69284A (en) Dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
EA200000792A3 (ru) Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
HK1032236A1 (en) New bicyclic amino-pyrazinone compounds, a processfor their preparation and pharmaceutical compositions containing them.
DK0635497T3 (da) Benzospiroalkenderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
NO20026004D0 (no) Nye podofyllotoksinkarbamat- og tiokarbamatforbindelser, fremgangsmåte vedderes fremstilling og farmasöytiske sammensetninger inneholdendedem
HUP0102350A2 (hu) Propenil-cefalosporin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
HU9603178D0 (en) Process for producing benzyl-ethers with phase transformation
HU902079D0 (en) Process for producing glutaric acid derivatives and pharmaceutical preparatives containing such compounds
HK1053793A1 (en) Pharmaceutical compositions containing oxapenem-3-carboxilic acids
NZ508141A (en) Substituted dithio-bis-nitrobenzenes and their use as screening inhibitors of NAD(P)H-dependent disulphide reductase enzymes
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
TH58467B (th) ไบไชโคล (2.2.1) เฮพเทนส์ และสารประกอบที่เกี่ยวข้อง
TH22954A (th) อนุพันธ์เฮเทอโรไซคลิค สไปโร

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120615